Position in ARVN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,794
-$1,322 QoQ
Shares Held
577
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#172
of 201 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atlantic Private Wealth, LLC holds $417,642 across 13 Biotechnology names. ARVN ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
2,600 | $211,926 | |
| 2 | SRPT |
Sarepta Therapeutics, Inc.
|
7,500 | $134,775 | |
| 3 | SLS |
SELLAS Life Sciences Group, Inc.
|
2,000 | $29,520 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
500 | $19,505 | |
| 5 | MRNA |
Moderna, Inc.
|
136 | $9,524 | |
| 6 | ARVN |
Arvinas, Inc.
This page
|
577 | $4,794 | |
| 7 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
500 | $4,690 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
15 | $818 |
All Filings in ARVN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,794 | 577 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,116 | 577 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,843 | 577 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,916 | 577 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,246 | 577 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,050 | 577 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $11,061 | 577 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $14,211 | 577 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||